E McCusker
Overview
Explore the profile of E McCusker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
600
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Ramos E, Lee J, Gillis T, Mysore J, Hayden M, et al.
Neurology
. 2012 Feb;
78(10):690-5.
PMID: 22323755
Objective: Age at onset of diagnostic motor manifestations in Huntington disease (HD) is strongly correlated with an expanded CAG trinucleotide repeat. The length of the normal CAG repeat allele has...
2.
Loy C, Lownie A, McCusker E
Lancet
. 2010 Nov;
376(9751):1463.
PMID: 21036269
No abstract available.
3.
Sivagangabalan G, McCusker E
Intern Med J
. 2003 Sep;
33(9-10):475.
PMID: 14511207
No abstract available.
4.
Caramins M, Halliday G, McCusker E, Trent R
J Neurol Neurosurg Psychiatry
. 2003 Jun;
74(7):968-70.
PMID: 12810795
Huntington's disease (HD) results from neurodegeneration of the neostriatum. The mutation on chromosome 4 is an expansion in a triplet repeat (CAG)(n) located within the IT15 gene. Only six patients...
5.
Djousse L, Knowlton B, Hayden M, Almqvist E, Brinkman R, Ross C, et al.
Am J Med Genet A
. 2003 Jun;
119A(3):279-82.
PMID: 12784292
Huntington disease (HD) is a neurodegenerative disorder caused by the abnormal expansion of CAG repeats in the HD gene on chromosome 4p16.3. Past studies have shown that the size of...
6.
Thieben M, Duggins A, Good C, Gomes L, Mahant N, Richards F, et al.
Brain
. 2002 Jul;
125(Pt 8):1815-28.
PMID: 12135972
Putative neuroprotective agents in Huntington's disease may have particular application before brain pathology becomes manifest clinically. If these agents were to be tested in clinical trials, a reliable marker of...
7.
McCusker E, Richards F, Sillence D, Wilson M, Trent R
J Clin Neurosci
. 2000 Jun;
7(1):38-41.
PMID: 10847649
One hundred and fifty-six potential gene carriers who were 50% 'at risk' of inheriting the Huntington's disease (HD) mutation, and who presented for predictive testing, underwent neurological assessment before their...
8.
Halliday G, McRitchie D, MacDonald V, Double K, Trent R, McCusker E
Exp Neurol
. 1999 Jan;
154(2):663-72.
PMID: 9878201
The present study analyzes the relationship between cortical and subcortical brain volumes in patients with Huntington's disease. The brains of seven patients with a clinical diagnosis and positive family history...
9.
Gun R, Korten A, Jorm A, Henderson A, Broe G, Creasey H, et al.
Alzheimer Dis Assoc Disord
. 1997 Mar;
11(1):21-7.
PMID: 9071441
There is evidence to support the role of a number of environmental factors in Alzheimer disease (AD). This study examines the role of chemical and physical exposures in the occupational...
10.
Reid W, Broe G, Creasey H, Grayson D, McCusker E, Bennett H, et al.
Arch Neurol
. 1996 Oct;
53(10):1056-61.
PMID: 8859068
Objectives: To examine the effects of age at onset on neuropsychological functioning in a group of patients with probable Alzheimer disease (AD) and, within this group, to scrutinize further those...